Actrapid Human


Indications and Reactions:

Role Indications Reactions
Secondary
Hypertension 20.4%
Diabetes Mellitus 19.9%
Cardiac Failure 14.4%
Renal Failure 9.9%
Atrial Fibrillation 5.0%
Coagulopathy 5.0%
Type 2 Diabetes Mellitus 5.0%
Ill-defined Disorder 4.4%
Pain 3.9%
Arrhythmia 1.7%
Colorectal Cancer 1.7%
Coronary Artery Disease 1.7%
Bronchitis Chronic 1.1%
Hypercholesterolaemia 1.1%
Mesenteric Vein Thrombosis 1.1%
Polyneuropathy 1.1%
Pulmonary Oedema 1.1%
Hepatitis B 0.6%
Hypothyroidism 0.6%
Neuroendocrine Tumour 0.6%
Depression 11.5%
Glycosylated Haemoglobin Increased 11.5%
Hyperglycaemia 11.5%
Right Ventricular Failure 11.5%
Haemorrhoidal Haemorrhage 7.7%
Loss Of Consciousness 7.7%
Syncope 7.7%
Agranulocytosis 3.8%
Cholestasis 3.8%
Delirium 3.8%
Diabetic Coma 3.8%
Drug Ineffective 3.8%
Gastrointestinal Haemorrhage 3.8%
Pain 3.8%
Toxic Epidermal Necrolysis 3.8%
Concomitant
Drug Use For Unknown Indication 19.4%
Hypertension 17.5%
Diabetes Mellitus 9.8%
Product Used For Unknown Indication 7.2%
Prophylaxis Against Renal Transplant Rejection 4.7%
Prophylaxis Against Transplant Rejection 4.5%
Prophylaxis 3.7%
Infection 3.6%
Metastatic Renal Cell Carcinoma 3.6%
Type 2 Diabetes Mellitus 3.6%
Chronic Obstructive Pulmonary Disease 3.2%
Coronary Artery Disease 2.5%
Pyrexia 2.5%
Vomiting 2.5%
Insomnia 2.4%
Renal Transplant 2.0%
Hyperglycaemia 1.9%
Hypercholesterolaemia 1.7%
Multiple Myeloma 1.7%
Peritoneal Dialysis 1.7%
Sepsis 8.9%
White Blood Cell Count Decreased 7.9%
Drug Interaction 6.9%
Ketosis 5.9%
Renal Failure 5.9%
Ureteric Obstruction 5.9%
Urinary Tract Infection 5.9%
White Blood Cell Count Increased 5.9%
Cerebral Haemorrhage 5.0%
Hepatitis Acute 5.0%
Plasmacytoma 5.0%
Renal Failure Acute 5.0%
Rhabdomyolysis 5.0%
Localised Infection 4.0%
Cardiac Arrest 3.0%
Clostridium Difficile Colitis 3.0%
Death 3.0%
Drug Ineffective 3.0%
Dyspnoea 3.0%
Faecaloma 3.0%

Drug Data